Hypothalamic-pituitary hormones during critical illness: A dynamic neuroendocrine response

Handbook of Clinical Neurology

Volumn 124, Issue , 2014, Pages 115-126

  Langouche, Lies ^a   Van den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cortisol; Critical illness; Endocrine changes; Gonadal; Growth hormone; Prolactin; Therapeutic implications; Thyroid

Indexed keywords

HYPOPHYSIS HORMONE;

ANIMAL; CRITICAL ILLNESS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; NEUROSECRETION; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CRITICAL ILLNESS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROSECRETION; NEUROSECRETORY SYSTEMS; PITUITARY HORMONES; PITUITARY-ADRENAL SYSTEM;

EID: 84907518544     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59602-4.00008-3     Document Type: Chapter

References (139)

1. Acker C.G., Singh A.R., Flick R.P., et al. A trial of thyroxine in acute renal failure. Kidney Int 2000, 57:293-298.
2. Angele M.K., Ayala A., Cioffi W.G., et al. Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. Am J Physiol 1998, 274:C1530-C1536.
3. Annane D., Sebille V., Troche G., et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000, 283:1038-1045.
4. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
5. Arnold J., Campbell I.T., Samuels T.A., et al. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci (Lond) 1993, 84:655-661.
6. Baricevic I., Jones D.R., Dordevic B., et al. Differential influence of open surgery and sepsis on the circulating insulin-like growth factors and their binding proteins as representative metabolic markers. Clin Biochem 2007, 40:1122-1128.
7. Barquist E., Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997, 42:27-31.
8. Baxter R.C. Changes in the IGF-IGFBP axis in critical illness. Best Pract Res Clin Endocrinol Metab 2001, 15:421-434.
9. Baxter R.C., Martin J.L. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc Natl Acad Sci U S A 1989, 86:6898-6902.
10. Baxter R.C., Hawker F.H., To C., et al. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Horm IGF Res 1998, 8:455-463.
11. Beishuizen A., Thijs L.G., Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001, 27:1584-1591.
12. Benedict C.R., Grahame-Smith D.G. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med 1978, 47:1-20.
13. Ben-Jonathan N., Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001, 22:724-763.
14. Bettendorf M., Schmidt K.G., Grulich-Henn J., et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000, 356:529-534.
15. Bianco A.C., Salvatore D., Gereben B., et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002, 23:38-89.
16. Bodenner D.L., Mroczynski M.A., Weintraub B.D., et al. A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene. J Biol Chem 1991, 266:21666-21673.
17. Boelen A., Platvoet-ter Schiphorst M.C., Bakker O., et al. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. J Endocrinol 1995, 146:475-483.
18. Boelen A., Wiersinga W.M., Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 2008, 18:123-129.
19. Boonen E., Vervenne H., Meersseman P., et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013, 368:1477-1488.
20. Bornstein S.R., Chrousos G.P. Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999, 84:1729-1736.
21. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., et al. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 2008, 19:175-180.
22. Brent G.A., Hershman J.M. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986, 63:1-8.
23. Burchard K. A review of the adrenal cortex and severe inflammation: quest of the "eucorticoid" state. J Trauma 2001, 51:800-814.
24. Christeff N., Benassayag C., Carli-Vielle C., et al. Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients. J Steroid Biochem 1988, 29:435-440.
25. Cooper M.S., Stewart P.M. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734.
26. De Groot L.J. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999, 84:151-164.
27. Debaveye Y., Ellger B., Mebis L., et al. Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology 2005, 146:5604-5611.
28. Defalque D., Brandt N., Ketelslegers J.M., et al. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol 1999, 276:E565-E572.
29. Devins S.S., Miller A., Herndon B.L., et al. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992, 20:1644-1649.
30. Dong Q., Hawker F., McWilliam D., et al. Circulating immunoreactive inhibin and testosterone levels in men with critical illness. Clin Endocrinol (Oxf) 1992, 36:399-404.
31. Dossett L.A., Swenson B.R., Heffernan D., et al. High levels of endogenous estrogens are associated with death in the critically injured adult. J Trauma 2008, 64:580-585.
32. Duska F., Fric M., Waldauf P., et al. Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation. Crit Care Med 2008, 36:1707-1713.
33. Faglia G., Ferrari C., Beck-Peccoz P., et al. Reduced plasma thyrotropin response to thyrotropin releasing hormone after dexamethasone administration in normal subjects. Horm Metab Res 1973, 5:289-292.
34. Felmet K.A., Hall M.W., Clark R.S., et al. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005, 174:3765-3772.
35. Ferrando A.A., Sheffield-Moore M., Wolf S.E., et al. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med 2001, 29:1936-1942.
36. Finlay W.E., McKee J.I. Serum cortisol levels in severely stressed patients. Lancet 1982, 1:1414-1415.
37. Fliers E., Guldenaar S.E., Wiersinga W.M., et al. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 1997, 82:4032-4036.
38. Fourrier F., Jallot A., Leclerc L., et al. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock 1994, 43:171-178.
39. Freeman M.E., Kanyicska B., Lerant A., et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000, 80:1523-1631.
40. Friesema E.C., Jansen J., Visser T.J. Thyroid hormone transporters. Biochem Soc Trans 2005, 33:228-232.
41. Fruchtman S., Jackson L., Borski R. Insulin-like growth factor I disparately regulates prolactin and growth hormone synthesis and secretion: studies using the teleost pituitary model. Endocrinology 2000, 141:2886-2894.
42. Gardner D.F., Kaplan M.M., Stanley C.A., et al. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979, 300:579-584.
43. Gilliver S.C. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010, 120:105-115.
44. Goldsmith R.E., Stanbury J.B., Brownell G.L. The effect of thyrotropin on the release of hormone from the human thyroid. J Clin Endocrinol Metab 1951, 11:1079-1094.
45. Guo H., Calkins J.H., Sigel M.M., et al. Interleukin-2 is a potent inhibitor of Leydig cell steroidogenesis. Endocrinology 1990, 127:1234-1239.
46. Hammond G.L., Smith C.L., Paterson N.A., et al. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab 1990, 71:34-39.
47. Hamrahian A.H., Oseni T.S., Arafah B.M. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004, 350:1629-1638.
48. Hermansson M., Wickelgren R.B., Hammarqvist F., et al. Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. J Clin Endocrinol Metab 1997, 82:421-428.
49. Herndon D.N., Barrow R.E., Kunkel K.R., et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990, 212:424-429.
50. Hill N.E., Murphy K.G., Singer M. Ghrelin, appetite and critical illness. Curr Opin Crit Care 2012, 18:199-205.
51. Howard A.D., Feighner S.D., Cully D.F., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
52. Juneja H.S., Karanth S., Dutt A., et al. Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men. Horm Res 1991, 35:89-94.
53. Kageyama K., Suda T. Role and action in the pituitary corticotroph of corticotropin-releasing factor (CRF) in the hypothalamus. Peptides 2009, 30:810-816.
54. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
55. Kupfer S.R., Underwood L.E., Baxter R.C., et al. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993, 91:391-396.
56. Lamberts S.W., Macleod R.M. Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 1990, 70:279-318.
57. Lim C.F., Docter R., Visser T.J., et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 1993, 76:1165-1172.
58. Maldonado L.S., Murata G.H., Hershman J.M., et al. Do thyroid function tests independently predict survival in the critically ill?. Thyroid 1992, 2:119-123.
59. Marik P.E., Zaloga G.P. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002, 122:1784-1796.
60. Mebis L., Van den Berghe G. Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinol Metab 2011, 25:745-757.
61. Mebis L., Langouche L., Visser T.J., et al. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab 2007, 92:3330-3333.
62. Mebis L., Debaveye Y., Ellger B., et al. Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Crit Care 2009, 13:R147.
63. Mebis L., Paletta D., Debaveye Y., et al. Expression of thyroid hormone transporters during critcal illness. Eur J Endocrinol 2009, 161:243-250.
64. Mebis L., Eerdekens A., Guiza F., et al. Contribution of nutritional deficit to the pathogenesis of the nonthyroidal illness syndrome in critical illness: a rabbit model study. Endocrinology 2012, 153:973-984.
65. Mesotten D., Van den Berghe G. Changes within the GH/IGF-I/IGFBP axis in critical illness. Crit Care Clin 2006, 22:17-28. v.
66. Mesotten D., Wouters P.J., Peeters R.P., et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab 2004, 89:3105-3113.
67. Michalaki M., Vagenakis A.G., Makri M., et al. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab 2001, 86:4198-4205.
68. Minneci P.C., Deans K.J., Banks S.M., et al. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004, 141:47-56.
69. Nematy M., O'Flynn J.E., Wandrag L., et al. Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care 2006, 10:R10.
70. Noel G.L., Suh H.K., Stone J.G., et al. Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab 1972, 35:840-851.
71. Ohlsson C., Mohan S., Sjogren K., et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev 2009, 30:494-535.
72. Oudemans-van Straaten H.M., Bosman R.J., Treskes M., et al. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27:84-90.
73. Peeters R.P., Wouters P.J., Kaptein E., et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 2003, 88:3202-3211.
74. Peeters R.P., Wouters P.J., van Toor H., et al. Serum rT3 and T3/rT3 are prognostic markers in critically ill patients and are associated with post-mortem tissue deiodinase activities. J Clin Endocrinol Metab 2005, 90:4559-4565.
75. Pemberton P.A., Stein P.E., Pepys M.B., et al. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 1988, 336:257-258.
76. Persani L., Terzolo M., Asteria C., et al. Circadian variations of thyrotropin bioactivity in normal subjects and patients with primary hypothyroidism. J Clin Endocrinol Metab 1995, 80:2722-2728.
77. Plymate S.R., Vaughan G.M., Mason A.D., et al. Central hypogonadism in burned men. Horm Res 1987, 27:152-158.
78. Popovic V., Miljic D., Micic D., et al. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab 2003, 88:3450-3453.
79. Popovic V., Miljic D., Pekic S., et al. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. J Clin Endocrinol Metab 2005, 90:2187-2191.
80. Ray D.C., Macduff A., Drummond G.B., et al. Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Med 2002, 28:1301-1308.
81. Reis F.M., Ribeiro-de-Oliveira J.A., Machado L.J., et al. Plasma prolactin and glucose alterations induced by surgical stress: a single or dual response?. Exp Physiol 1998, 83:1-10.
82. Roberts I., Yates D., Sandercock P., et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004, 364:1321-1328.
83. Rodas P.C., Rooyackers O., Hebert C., et al. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012, 122:591-597.
84. Rodriguez-Perez A., Palos-Paz F., Kaptein E., et al. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol (Oxf) 2008, 68:821-827.
85. Romijn J.A., Wiersinga W.M. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 1990, 70:35-42.
86. Ross R., Miell J., Freeman E., et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 1991, 35:47-54.
87. Rothwell P.M., Lawler P.G. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995, 23:78-83.
88. Rothwell P.M., Udwadia Z.F., Lawler P.G. Cortisol response to corticotropin and survival in septic shock. Lancet 1991, 337:582-583.
89. Rothwell P.M., Udwadia Z.F., Lawler P.G. Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 1993, 48:373-376.
90. Russell D.H. New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci 1989, 10:40-44.
91. Sam S., Corbridge T.C., Mokhlesi B., et al. Cortisol levels and mortality in severe sepsis. Clin Endocrinol (Oxf) 2004, 60:29-35.
92. Schlienger J.L., Sapin R., Capgras T., et al. Evaluation of thyroid function after myocardial infarction. Ann Endocrinol (Paris) 1991, 52:283-288.
93. Schuetz P., Muller B., Nusbaumer C., et al. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. Eur J Endocrinol 2009, 160:157-163.
94. Semple C.G., Robertson W.R., Mitchell R., et al. Mechanisms leading to hypogonadism in men with burns injuries. Br Med J (Clin Res Ed) 1987, 295:403-407.
95. Span L.F., Hermus A.R., Bartelink A.K., et al. Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 1992, 18:93-96.
96. Spratt D.I., Cox P., Orav J., et al. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 1993, 76:1548-1554.
97. Spratt D.I., Longcope C., Cox P.M., et al. Differential changes in serum concentrations of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness. J Clin Endocrinol Metab 1993, 76:1542-1547.
98. Spratt D.I., Morton J.R., Kramer R.S., et al. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab 2006, 291:E631-E638.
99. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
100. Stefaneanu L., Powell-Braxton L., Won W., et al. Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. Endocrinology 1999, 140:3881-3889.
101. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341:785-792.
102. Tannenbaum G.S., Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 1984, 115:1952-1957.
103. Tannenbaum G.S., Epelbaum J., Bowers C.Y. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 2003, 144:967-974.
104. Thijssen-Timmer D.C., Peeters R.P., Wouters P., et al. Thyroid hormone receptor isoform expression in livers of critically ill patients. Thyroid 2007, 17:105-112.
105. Timmins A.C., Cotterill A.M., Hughes S.C., et al. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 1996, 24:1460-1466.
106. Vale W., Blackwell R., Grant G., et al. TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. Endocrinology 1973, 93:26-33.
107. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000, 143:1-13.
108. Van den Berghe G., de Zegher F., Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf) 1994, 41:731-737.
109. Van den Berghe G., de Zegher F., Lauwers P., et al. Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine. Clin Endocrinol (Oxf) 1994, 41:563-569.
110. Van den Berghe G., de Zegher F., Vlasselaers D., et al. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. Crit Care Med 1996, 24:590-595.
111. Van den Berghe G., de Zegher F., Bowers C.Y., et al. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Clin Endocrinol (Oxf) 1996, 45:341-351.
112. Van den Berghe G., de Zegher F., Veldhuis J.D., et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab 1997, 82:590-599.
113. Van den Berghe G., de Zegher F., Veldhuis J.D., et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf) 1997, 47:599-612.
114. Van den Berghe G., de Zegher F., Baxter R.C., et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 1998, 83:309-319.
115. Van den Berghe G., de Zegher F., Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998, 83:1827-1834.
116. Van den Berghe G., Wouters P., Weekers F., et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999, 84:1311-1323.
117. Van den Berghe G., Baxter R.C., Weekers F., et al. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab 2000, 85:183-192.
118. Van den Berghe G., Weekers F., Baxter R.C., et al. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab 2001, 86:3217-3226.
119. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367.
120. Van den Berghe G., Baxter R.C., Weekers F., et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002, 56:655-669.
121. Van der Poll T., Romijn J.A., Wiersinga W.M., et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990, 71:1567-1572.
122. Van der Poll T., Van Zee K.J., Endert E., et al. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab 1995, 80:1341-1346.
123. Van der Poll T., Endert E., Coyle S.M., et al. Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans. Am J Physiol 1999, 276:R357-R362.
124. Vanhorebeek I., Peeters R.P., Vander Perre S., et al. Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 2006, 91:3803-3813.
125. Vermes I., Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 2001, 15:495-511.
126. Voerman B.J., Strack van Schijndel R.J., Groeneveld A.B., et al. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit Care Med 1995, 23:665-673.
127. Vogel A.V., Peake G.T., Rada R.T. Pituitary-testicular axis dysfunction in burned men. J Clin Endocrinol Metab 1985, 60:658-665.
128. Wang C., Chan V., Tse T.F., et al. Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol (Oxf) 1978, 9:249-253.
129. Wang C., Chan V., Yeung R.T. Effect of surgical stress on pituitary-testicular function. Clin Endocrinol (Oxf) 1978, 9:255-266.
130. Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev 1982, 3:164-217.
131. Weekers F., Van Herck E., Coopmans W., et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 2002, 143:764-774.
132. Weintraub B.D., Wondisford F.E., Farr E.A., et al. Pre-translational and post-translational regulation of TSH synthesis in normal and neoplastic thyrotrophs. Horm Res 1989, 32:22-24.
133. Wigginton J.G., Pepe P.E., Idris A.H. Rationale for routine and immediate administration of intravenous estrogen for all critically ill and injured patients. Crit Care Med 2010, 38:S620-S629.
134. Woolf P.D., Hamill R.W., McDonald J.V., et al. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985, 60:444-450.
135. Wu R., Zhou M., Cui X., et al. Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am J Physiol Heart Circ Physiol 2004, 287:H1296-H1302.
136. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001, 81:1097-1142.
137. Zellweger R., Wichmann M.W., Ayala A., et al. Prolactin: a novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage. J Surg Res 1996, 63:53-58.
138. Zellweger R., Wichmann M.W., Ayala A., et al. Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage. J Trauma 1998, 44:70-77.
139. Ziegler T.R., Young L.S., Ferrari-Baliviera E., et al. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN J Parenter Enteral Nutr 1990, 14:574-581.